KPQ-18027-50353
3 vaccinations
5 coded responses
31 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 015 / MA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-08
- 2021-02-13
- 2021-02-20
-
2021-02-21
Dose 2 — Pfizer-BioNTech
-
2021-02-28
Survey response — day 7, dose 2MedDRA: Fatigue — Feeling: GoodFree text: Consistent fatigue over past week after 2nd shot. This is the first day that I feel better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-14
-
2021-03-23
Survey response — day 28, dose 2MedDRA: Pre-existing disease — Feeling: FairFree text: Seasonal allergies,MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — day 35, dose 2MedDRA: Type 2 diabetes mellitus, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Newly diagnosed with type 2 diabetes. · Healthcare visit (other): Blood draw at lab.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-04
- 2021-05-23
- 2021-08-22
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-06
-
2021-10-07
Health check-in — day 7, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-14
- 2021-10-21
-
2021-10-28
Survey response — day 28, dose 3MedDRA: Skin infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Skin infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-29
-
2021-11-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: Caesarean section, Hypertension, Muscle spasms, Office visit, Postpartum haemorrhage — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Gave birth by cesarean section on (b)(6). I have had some postpartum high blood pressure, currently well-managed with enalapril. I am also experiencing ongoing issues with postpartum bleeding and cramping, liked related to problems with IUD placed in c · Healthcare visit (other): Urgent postpartum visit to labor and delivery triage, treated but not admitted.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-21 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Consistent fatigue over past week after 2nd shot. This is the first day that I feel better.
Release 6 — day 28, dose 2
Symptoms: Seasonal allergies,
Release 6 — day 35, dose 2
Symptoms: Newly diagnosed with type 2 diabetes.
Healthcare visit (other): Blood draw at lab.
Release 10 — day 28, dose 3
Symptoms: Skin infection
Release 12 — 12 months, dose 3
Symptoms: Gave birth by cesarean section on (b)(6). I have had some postpartum high blood pressure, currently well-managed with enalapril. I am also experiencing ongoing issues with postpartum bleeding and cramping, liked related to problems with IUD placed in c cut off by CDC
Healthcare visit (other): Urgent postpartum visit to labor and delivery triage, treated but not admitted.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Postpartum haemorrhage | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Skin infection | · | · | ✓ |
| SD | Type 2 diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release